Jensen Margaret E. Valeur

General Counsel, Neurocrine Biosciences.

Companies

Travere Therapeutics, Inc.General counsel Nov 17, 2014 to Feb 2, 2016¹
Neurocrine BiosciencesGeneral counsel Jan 23, 2006 to Sep 1, 2011²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTravere Therapeutics, Inc., General counsel
2
SEC EDGARNeurocrine Biosciences, General counsel